21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN
#10202Lipid formulation
#10203COMBINATION COMPRISING PYRROLIDONE-5-CARBOXYLIC ACID AND AT LEAST ONE COMPOUND FROM CITRULLINE, ARGININE AND ASPRAGINE, AND USE THEREOF IN THE TRATMENT OF ATOPIC DERMATITIS
#10204COMBINED USE OF ANGIOGENESIS INHIBITOR AND TAXANE
#10205Combinations of Organic Compounds
#10206THERAPEUTIC USE OF CARBOXYL ESTER LIPASE INHIBITORS
#10207PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING HCV
#10208PHARMACEUTICAL COMPOSITIONS USEFUL FOR TREATING HCV
#10209INHIBITORS OF BRUTON'S TYROSINE KINASE
#10210Methods of Using SAHA for Treating HIV Infection
#10211Aqueous pharmaceutical compositions containing borate-polyol complexes
#10212Inhaled combination therapy
#10213TOPICAL COMPOSITION CONTAINING THE COMBINATION OF MUPIROCIN AND BECLOMETHASONE
#10214Method of treating female sexual dysfunction with a PDE1 inhibitor
#10215METHODS AND PRODUCTS FOR TREATMENT OF DISEASES
#10216PHARMACEUTICAL COMBINATIONS USEFUL FOR TREATING HCV
#10217COMBINATIONS OF RETIGABINE AND SODIUM CHANNEL INHIBITORS OR SODIUM CHANNEL-INFLUENCING ACTIVE COMPOUNDS FOR TREATING PAINS
#10218PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME
#10219Food composition for prodromal dementia patients
#10220METHODS AND COMPOSITIONS FOR INHIBITING PROLIFERATION OF ANEUPLOID CELLS
#10221NON-IMMUNOSUPPRESSIVE CYCLOSPORIN FOR THE TREATMENT OF MUSCULAR DYSTROPHY
#10222METHODS FOR TREATING OBESITY AND OBESITY RELATED DISEASES AND DISORDERS
#10223Nucleoside Analogs in Combination Therapy of Herpes Simplex Infections
#10224Antimicrobial Compositions and Methods of Making and Using the Same
#10225METHODS AND THERAPEUTIC COMPOSITIONS COMPRISING PLANT EXTRACTS FOR THE TREATMENT OF CANCER
#10226COSMETIC COMPOSITION FOR TOPICAL USE COMPRISING WASABI
#10227Method for determination of sensitivity to anti-cancer agent
#10228Agent for treating ulcer
#10229Synergistic combination to enhance blood glucose and insulin metabolism
#10230Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy and anti-cancer activity and methods of use
#10231METHOD AND COMPOSITION FOR TREATING PULMONARY HEMORRHAGE
#10232Solid dosage form comprising a fibrate
#10233Non-pegylated liposomal doxorubicin triple combination therapy
#10234Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
#10235TONIC AND FOOD SUPPLEMENT COMPRISING ALOE VERA AND HONEY
#10236THERAPEUTIC AND PROPHYLACTIC METHODS FOR NEUROMUSCULAR DISORDERS
#10237NOVEL METHODS FOR TREATING EGFR-ASSOCIATED TUMORS
#10238Protease variants for pharmaceutical use
#10239Combination Enzyme Therapy for Gastric Digestion of Dietary Gluten in Celiac Sprue Patients
#10240COMPOSITION COMPRISING BIFIDOBACTERIUM INFANTIS AND FRUCTO- AND GALACTO-OLIGOSACCHARIDES FOR THE PREVENTION OF INTESTINAL DISCOMFORT IN INFANTS
#10241Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
#10242Treatment of multiple sclerosis with laquinimod
#10243Methods of improving central nervous system functioning
#10244CHARACTERIZATION OF IL-17F AND IL-17R INTERACTIONS
#10245T CELL DEPLETING COMPOSITIONS USEFUL FOR TREATING CANCER
#10246Combination therapies for treating type 1 diabetes
#10247Immuniostimulating polyphosphazene compounds
#10248BEVERAGE COMPRISING ARGININE
#10249NOVEL METHODS AND MEDICAMENT FOR TREATING INFECTIOUS DISEASES INVOLVING MICROBIAL BIOFILMS
#10250ENHANCED B CELL CYTOTOXICITY OF CDIM BINDING ANTIBODY
#10251HEMOSTATIC MATERIAL AND DELIVERY DEVICE
#10252Catheter locking solution having antimicrobial and anticoagulation properties
#10253COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH NEURONAL DYSFUNCTION
#10254FREE FATTY ACID BLENDS AND USE THEREOF
#10255NEW PHARMACEUTICAL FORMULATION COMPRISING CANNABIDIOL AND TETRAHYDROCANNABIDIVARIN
#10256METHODS FOR TREATING NEUROPSYCHIATRIC CONDITIONS
#102571-aryl- or 1-heteroaryl-pyrido[B]indoles and uses thereof in treating cancers
#10258Composition Comprising An NK-1 Receptor Antagonist And An SSRI For The Treatment Of Tinnitus And Hearing Loss
#10259REDUCING THE RISK OF CHRONIC LUNG DISEASE IN INFANTS
#10260Silver nanoparticles as anti-microbial
#10261Nutritive compositions and methods of using same
#10262Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders
#10263Methods for treating breast cancer using NRIF3 related molecules
#10264Method for topical treatment of eye disease and composition and device for said treatment
#10265TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH AN ANTINEOPLASTIC HEAT SHOCK APOPTOSIS ACTIVATOR (HSAA)
#10266PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLE-O-GLUCOSIDE DERIVATIVE
#10267Diketopiperazine microparticles with defined isomer contents
#10268PHARMACEUTICAL COMPOSITION COMPRISING TESOFENSINE OR ITS ANALOGUE AND AN ANTI-OBESITY COMPOUND
#10269Composition and Method for the Treatment of Diseases Affected by a Peptide Receptor
#10270Novel Peptides and Their Use for the Treatment of Edema
#10271FACTOR
#10272Bioassay method for yokukansan with serotonin receptor
#10273DIETARY SUPPLEMENTS CONTAINING PROBIOTICS
#10274Nutritionally Fortified Liquid Composition With Added Value Delivery Systems/Elements/Additives
#10275Nutritional supplement
#10276CHOLESTEROL LOWERING SUPPLEMENT
#10277Combinations of herb extracts having synergistic antioxidant effect, and methods relating thereto
#10278Systems and methods for treating fibromyalgia
#10279Chitosan gel for dermatological use, production method therefor and use of same
#10280HOMEOPATHIC COMPLEX
#10281COMPOSITIONS AND METHODS FOR REDUCING HANGOVER SYMPTOMS
#10282METHODS OF THERMOGRAPH-GUIDED MEDICAL TREATMENT
#10283Hyperbaric Oxygen Therapy and Treatment Method
#10284BEVERAGE COMPOSITIONS FOR THE PROMOTION OF JOINT HEALTH IN COMPANION ANIMALS
#10285TREATMENT OF INFLAMMATORY DISORDERS WITH OZONE
#10286Methods of treating disease with random copolymers
#10287PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS
#10288Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
#10289Compositions and method for manipulating PIM-1 activity in circulatory system cells
#10290SYSTEMIC ADMINISTRATION OF LIPOSOMAL REDUCED GLUTATHIONE FOR THE DECORPORATION OF RADIOACTIVE MATERIALS AND NON-RADIOACTIVE MERCURY
#10291Product and method for reducing substance craving
#10292Dental uses of silver hydrosol
#10293Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
#10294BIOMARKERS FOR IGF-1R INHIBITOR THERAPY
#10295Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs
#10296Compositions and methods for diagnosing and treating cancer
#10297Method of treating rheumatoid arthritis with an IL-6R antibody
#10298PROPHYLATIC AGENT FOR AUTOIMMUNE DISEASE
#10299COMPOSITIONS AND METHODS FOR URINARY BLADDER REGENERATION
#10300Conditionally Replicating Viruses for Cancer Therapy
#10301Hepatitis C virus inhibitors
#10302MODIFIED 2' AND 3' NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#10303Bioabsorbable polymers
#10304ORAL CARE PRODUCT AND METHODS OF USE THEREOF
#10305RADIOLABELED HEDGEHOG DERIVATIVES FOR IMAGING AND THERAPY
#10306Reduction of sterols and other compounds from oils
#10307N-halogenated amino compounds and derivatives
#10308Combination Therapy For Modulating The Human Sexual Response
#10309Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer
#10310Pharmaceutical Composition For The Parenteral Administration Of Ultrashort-Effective Beta-Adrenoreceptor Antagonists
#10311NORIBOGAINE IN THE TREATMENT OF PAIN AND DRUG ADDICTION
#10312Noribogaine in the treatment of pain and drug addiction
#10313NORIBOGAINE IN THE TREATMENT OF PAIN AND DRUG ADDICTION
#10314NORIBOGAINE IN THE TREATMENT OF PAIN AND DRUG ADDICTION
#10315Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication
#10316METHODS AND COMPOSITIONS FOR RETARDING WEIGHT GAIN ASSOCIATED WITH USE OF ATYPICAL ANTIPSYCHOTIC DRUGS
#10317METHOD OF TREATMENT OF ALLERGIC RHINITIS
#10318Transdermal preparation for external use containing nonsterioidal antiinflammatory/analgesic agent
#10319Methods and compositions for the treatment of CNS-related conditions
#10320Combination therapy with organic arsenicals
#10321Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines
#10322METHODS AND COMPOSITIONS FOR TREATING CANCER AND MODULATING SIGNAL TRANSDUCTION AND METABOLISM PATHWAYS
#10323PHARMACEUTICAL COMPOSITIONS WITH A MECHANISM OF MULTI-TARGET RECEPTOR RETROACTION FOR TREATING DEPRESSION
#10324PERSONAL CARE AND COSMETIC COMPOSITION CONTAINING TETRAPEPTIDES WITH THE MOTIFS GX1X2G, PX1X2P, OR PX1X2K
#10325Method and composition for potentiating an opiate analgesic
#10326USE OF GLP-1 AS A THERAPEUTIC AGENT
#10327USE OF V2 RECEPTOR ANTAGONISTS IN COMBINATION WITH VASO PRESSINERGIC AGNOSTS
#10328Inhibitors of NCchannels for therapy
#10329Novel Preparation of an Enteric Release System
#10330Pharmaceutical product and analysis model for hormone replacement therapy for women and prevention of some cancers and uterine myomas
#10331ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE
#10332PHARMACEUTICAL COMPOSITIONS FOR TREATING DEPRESSION AND ANXIETY
#10333PHARMACEUTICAL COMPOSITIONS FOR TREATING ANXIETY
#10334Modulation of KCNQ potassium channel activity for treatment of psychiatric disorders and the symptoms thereof
#10335COMPOSITION AND METHOD FOR TREATING ACNE
#10336Compositions and Methods for Nutrition Supplementation
#10337Stable amorphous calcium carbonate comprising phosphorylated amino acids
#10338NOVEL COMPOSITION FOR TREATING THE SIDE EFFECTS OF ANTICANCER TREATMENTS
#10339BACTERIOSTATIC OR BACTERIOCIDAL COMPOSITIONS AND METHODS
#10340Compositions and methods for treating insulin resistance and diabetes mellitus
#10341HOMEOPATHIC REMEDIES FOR USE BEFORE AND AFTER AESTHETIC INJECTABLE AND SURGICAL PROCEDURES TO MINIMIZE SWELLING AND BRUISING
#10342Pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation
#10343Therapeutic approaches for treating CMT and related disorders
#10344Liposomes comprising duramycin and anti-viral agents
#10345ERYTHROPOIETIN AND FIBRONECTIN COMPOSITIONS FOR BONE REGENERATION
#10346COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES
#10347COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC)
#10348METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF STATIN-INDUCED MYOPATHY
#10349MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#10350Methods for Reversing Multiple Resistance in Animal Cells
#10351Treatment of inflammatory diseases
#10352Dry treatment mixture and methods of production and use
#10353COMPOSITION COMPRISING CALCIUM IONS AND AT LEAST ONE PROTEOLYTIC ENZYME FOR USE IN THE IN VITRO AND IN VIVO REGENERATION OF CUTANEOUS AND CONNECTIVE TISSUES
#10354Pharmaceutical Compositions for treating wouds and related methods
#10355Compositions suitable for treatment of spinal disease, disorder or condition
#10356Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy
#10357Pharmaceutical composition or combination drug
#10358Pharmaceutical compositions based on anticholingerics and additional active ingredients
#10359ANTIOXIDANT AND PARAMAGNETIC HEPARIN-NITROXIDE DERIVATIVES
#10360VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS
#10361COMBINATION OF AN ANTI-EDB FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND A MOLECULE BINDING TO B CELLS, B CELL PROGENITORS AND /OR THEIR CANCEROUS COUNTERPART
#10362Medical electrode containing a hydrophilic polymer
#10363Gas mist pressure bath system
#10364COMPOSITION USEFUL FOR THE PREVENTION OF ADVERSE EFFECT DUE TO THE USE OF PPAR-GAMMA AGONISTS
#10365THERAPEUTIC REGIMEN FOR TREATING CANCER
#10366METHOD AND COMPOSITION FOR REDUCING REPERFUSION INJURY
#10367Pharmaceutical composition
#10368Methods for concomitant administration of colchicine and a second active agent
#10369Methods for concomitant administration of colchicine and a second active agent
#10370PHARMACEUTICAL FORMULATIONS COMPRISING NSAID AND PROTON PUMP INHIBITOR DRUGS
#10371Anesthetic methods and compositions
#10372O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
#10373NASAL SPRAY DEVICE AND METHOD OF USE THEREOF
#10374Heterocycle-substituted piperazino-dihydrothienopyrimidines
#10375Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
#10376Pharmaceutical compositions for the treatment of pain
#10377Method of treating human preeclampsia employing resibufagenin
#10378Composition and method of treating hearing loss
#10379NIACIN-BASED PHARMACEUTICAL COMPOSITIONS
#10380Synergistic pharmaceutical combination for the treatment of cancer
#10381CONCENTRATED AQUEOUS AZALIDE FORMULATIONS
#10382NOVEL USE OF CYTOKINE INHIBITORS
#10383Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative
#10384NOVEL COMPOSITION TO INCREASE TESTOSTERONE LEVELS
#10385METHOD OF REDUCING FAT ACCUMULATION AND INDUCING WEIGHT LOSS
#10386Medicinal Composition
#10387Method for Attenuating the Effects of Botulinum Toxin
#10388REMINERALISATION OF CALCIFIED TISSUE
#10389Pharmaceutical Compositions Comprising Cereal Beta (1-3) Beta (1-4) Glucan
#10390COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISORDERS
#10391Tablet with remedial composition and methods for treating medical disorders and ailments
#10392METHODS OF ENHANCING SELECTIVE SEROTONIN REUPTAKE INHIBITOR EFFECTS IN MAMMALS
#10393treatment
#10394DHA and PEDF, a Therapeutic Composition for Nerve and Retinal Pigment Epithelial Cells
#10395Controlled Release Hydrogel Films
#10396COMPOSITIONS AND METHODS FOR MODULATING CELLULAR MEMBRANE-MEDIATED INTRACELLULAR SIGNAL TRANSDUCTION
#10397Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
#10398METHOD OF REDUCING ADVERSE EFFECTS OF THERAPEUTIC AGENTS FOR DYSLIPIDEMIA
#10399Botanical anti-acne formulations
#10400Methods and compositions for treatment of cancer using oncolytic RSV activity
#10401Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
#10402Anti-estrogen and immune modulator combinations for treating breast cancer
#10403METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra
#10404METHOD FOR TREATING LUPUS
#10405Treatment of conditions related to shock
#10406Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
#10407MARKER OF PROSTATE CANCER
#10408COMBINATION THERAPY FOR CARDIAC REVASCULARIZATION AND CARDIAC REPAIR
#10409Preparation for the prevention and/or treatment of vascular disorders
#10410Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
#10411TREATMENT AND/OR PREVENTION OF CANCER AND/OR ARTHRITIS
#10412Skin compositions containing hydrocortisone
#10413Anti-cancer compounds
#10414Multi-part substitution infusion fluids and matching anticoagulants
#10415Branched chain fatty acids for prevention or treatment of gastrointestinal disorders
#10416Continuous administration of dopa decarboxylase inhibitors and compositions for same
#10417Continuous administration of dopa decarboxylase inhibitors and compositions for same
#10418Derivatives of taxol and closely related compounds
#10419Disulfide chemotherapeutic agents and methods of use thereof
#10420Manufacture, compositions and uses of coagulation factor VIIa modulator
#10421Pharmaceutical compositions of 5-hydroxytryptophan and serotonin-enhancing compound
#10422MEDICAMENT COMPRISING A CARBOSTYRIL DERIVATIVE AND DONEPEZIL FOR TREATING ALZHEIMER'S DISEASE
#10423Preparations and Methods for Ameliorating or Reducing Presbyopia
#10424COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL
#10425Ketone bodies and ketone body esters as blood lipid lowering agents
#10426Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
#10427Thyroid receptor ligands
#10428Controlled release formulations of levodopa and uses thereof
#10429Edible compositions for lowering cholesterol
#10430PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME
#10431Analgesic compositions
#10432ORGAN ARREST, PROTECTION AND PRESERVATION
#10433Compositions and methods for extracting and using phytochemicals for the treatment of influenza
#10434PHARMACEUTICAL OR COSMETIC PREPARATIONS FOR TOPICAL AND/OR PARENTERAL APPLICATION, PREPARATION METHODS THEREOF AND USE OF SAME
#10435COMPOSITION FOR THE PREVENTION AND THE TREATMENT OF HELICOBACTER PYLORI INFECTION
#10436COMBINATION THERAPY WITH SGLT-2 INHIBITORS AND THEIR PHARMACEUTICAL COMPOSITIONS
#10437USE OF TRUNCATED CYSTEINE IL28 AND IL29 MUTANTS TO TREAT CANCERS AND AUTOIMMUNE DISORDERS
#10438Use of an agent that restores tissue perfusion and oxygenation
#10439Biofilm prevention using lactoferrin
#10440METHODS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS RELATED TO GASTRIC ACID SECRETION
#10441PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF PROSTATE CANCER
#10442Placental stem cell populations
#10443Compositions and methods for reducing hepatotoxicity associated with drug administration
#10444COMPOSITION FOR TREATMENT OF ISCHEMIC HEART DISEASE, FACILITATION OF BLOOD CIRCULATION AND ANGIOGENESIS, IMPROVING SKIN BEAUTY, IMPROVING MALE SEXUAL FUNCTION CONTAINING GINSENG BERRY EXTRACT
#10445Compositions for diabetes treatment and prophylaxis
#10446Optimal compositions and methods for treating oral disease and pain
#10447COLON CLEANSING COMPOSITIONS AND METHODS
#10448PHARMACEUTICALLY ACTIVE COMPOSITIONS COMPRISING OXIDATIVE STRESS MODULATORS (OSM), NEW CHEMICAL ENTITIES, COMPOSITIONS AND USES
#10449Nutraceutical composition and methods of use
#10450COMPOSITIONS AND METHODS FOR PROSTATE AND MENSTRUAL/MENOPAUSAL RELATED HEALTH
#10451TAPENTADOL COMPOSITIONS
#10452Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
#10453Methods of therapeutic treatment of eyes
#10454AMPA Receptor Antagonists for Epilepsy, Mental Disorders or Deficits in Sensory Organ
#10455Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy
#10456Monoclonal antibody
#10457COMBINATION THERAPY TO INHIBIT T CELL EFFECTOR FUNCTION
#10458Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 Antagonists and TrkB Agonists
#10459Therapeutic Cancer Treatments
#10460Quinone derivatives, pharmaceutical compositions, and uses thereof
#10461COMBINATIONS COMPRISING DMXAA FOR THE TREATMENT OF CANCER
#10462Method to treat and prevent skin diseases with Porifera-based therapeutic compositions treating and preventing skin diseases
#10463Bacteriophage preparations and methods of use thereof
#10464COMBINATIONAL COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
#10465Wound healing compositions, systems, and methods
#10466Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy
#10467Immune response inducer
#10468Cytokine zalpha11 ligand antibodies
#10469CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#10470ENHANCEMENT OF ANTIBODY-CYTOKINE FUSION PROTEIN MEDIATED IMMUNE RESPONSES BY COMBINED TREATMENT WITH IMMUNOCYTOKINE UPTAKE ENHANCING AGENTS
#10471Megaribavirin alone or combination of other antiviral, antioxidant and a perflubron emulsion for treatment of viral disease
#10472MEDICAMENT COMBINATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES
#10473Promoter inducible by reactive oxygen species and vector comprising the same
#10474PHOSPHORYLATED AND PHOSPHONATED PYRONE ANALOGS FOR THERAPEUTIC TREATMENT
#10475Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors
#10476Fully synthetic implantable multi-phased scaffold
#10477Methods and Related Compositions for Reduction of Fat and Skin Tightening
#10478Methods and compositions for treating thalamocortical dysrhythmia
#10479Polar hydrophilic prodrugs and non-standard amino acid conjugates of amphetamine and other stimulants and processes for making and using the same
#10480COMPOSITIONS SUITABLE FOR THE TOPICAL TREATMENT OF FUNGAL INFECTIONS OF THE SKIN AND NAILS
#10481Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine
#10482COMPOSITIONS AND METHODS FOR ENHANCING COGNITIVE FUNCTION
#10483ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#10484INDUCING IMMUNE-MEDIATED TUMOR CELL DEATH
#10485TREATMENT OF MCI AND ALZHEIMER'S DISEASE
#10486Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#10487Combination preparations comprising SLV308 and a dopamine agonist
#10488RANOLAZINE FOR THE TREATMENT OF CNS DISORDERS
#10489Methods and Compositions for the Treatment of Psychiatric Conditions
#10490Formulas comprising highly soluble elements and vitamins for the prevention and amelioration of osteoporosis
#10491RADIOPROTECTIVE DRUGS
#10492BETA-LACTAMASE INHIBITORS
#10493TETRACYCLINE AND USES THEREOF
#10494Cystitis treatment with high dose chondroitin sulfate
#10495Method of treating non-insulin dependent diabetes mellitus and related complications
#10496Methods of treatment using combination therapy
#10497Combination Treatments for Alzheimer's Disease and Similar Diseases
#10498Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof
#10499Treatment of Menorrhagia with Aromatase Inhibitor
#10500Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level